250 related articles for article (PubMed ID: 8656249)
1. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
[TBL] [Abstract][Full Text] [Related]
2. Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease in gastric cancer.
Seeliger H; Spatz H; Jauch KW
Recent Results Cancer Res; 2003; 162():79-87. PubMed ID: 12790323
[TBL] [Abstract][Full Text] [Related]
5. [Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].
Broll R; Lembcke K; Stock C; Zingler M; Duchrow M; Schimmelpenning H; Strik M; Muller G; Kujath P; Bruch HP
Langenbecks Arch Chir; 1996; 381(1):51-8. PubMed ID: 8717176
[TBL] [Abstract][Full Text] [Related]
6. The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients.
de Manzoni G; Pelosi G; Pavanel F; Di Leo A; Pedrazzani C; Durante E; Cordiano C; Pasini F
Br J Cancer; 2002 Apr; 86(7):1047-51. PubMed ID: 11953846
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
8. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
[TBL] [Abstract][Full Text] [Related]
9. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Thorban S; Roder JD; Nekarda H; Funk A; Siewert JR; Pantel K
J Natl Cancer Inst; 1996 Sep; 88(17):1222-7. PubMed ID: 8780632
[TBL] [Abstract][Full Text] [Related]
13. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer.
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Ann Thorac Surg; 1999 Dec; 68(6):2053-8. PubMed ID: 10616976
[TBL] [Abstract][Full Text] [Related]
14. Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse.
Braun S; Schindlbeck C; Hepp F; Janni W; Kentenich C; Riethmüller G; Pantel K
J Clin Oncol; 2001 Jan; 19(2):368-75. PubMed ID: 11208828
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer.
Osaki T; Oyama T; Gu CD; Yamashita T; So T; Takenoyama M; Sugio K; Yasumoto K
J Clin Oncol; 2002 Jul; 20(13):2930-6. PubMed ID: 12089221
[TBL] [Abstract][Full Text] [Related]
16. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
17. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
[TBL] [Abstract][Full Text] [Related]
18. [Immunocytochemical detection of cytokeratin positive cells in human bone marrow of gastric and colorectal cancer patients].
Leinung S; Schönfelder A; Schönfelder M
Zentralbl Chir; 1998; 123(5):520-4. PubMed ID: 22462221
[TBL] [Abstract][Full Text] [Related]
19. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients.
Gretschel S; Schick C; Schneider U; Estevez-Schwarz L; Bembenek A; Schlag PM
Ann Surg Oncol; 2007 Feb; 14(2):373-80. PubMed ID: 17080240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
